FCL

- ICRA Limited has upgraded Fineotex Chemical Limited's long-term credit rating to [ICRA]AA- (Stable) from [ICRA]A+ (Positive), effective August 24, 2026. - The short-term rating was reaffirmed at [ICRA]A1+. - The upgrade reflects stronger scale, diversification, and an improved financial risk profile, partly due to a recent US acquisition.

- Fineotex Chemical Limited's Long-Term Credit Rating upgraded by ICRA to [ICRA]AA- (Stable) from [ICRA]A+ (Positive) as of August 24, 2026. - Short-Term Rating reaffirmed at [ICRA]A1+. - Upgrade driven by improved scale, diversification, and strong financial risk profile, particularly due to the FY2026 US acquisition.

- Board meeting approved the 23rd Annual General Meeting (AGM) to be held on September 11, 2026. - Record date for AGM and final dividend (if declared) is September 04, 2026, with payment by September 30, 2026. - Proposal for raising funds through issue of equity or equity-linked securities was also approved, subject to member and regulatory approvals.

- Board meeting on August 17, 2026, approved the 23rd AGM on September 11, 2026. - Record date for final dividend and AGM: September 04, 2026; payment by September 30, 2026. - Proposal for raising funds via equity or equity-linked securities also approved.

- Board of Directors meeting held on August 17, 2026. - 23rd Annual General Meeting (AGM) scheduled for September 11, 2026, at 4:00 P.M. - Record date for AGM and final dividend is September 04, 2026. - Dividend, if declared, will be paid by September 30, 2026. - Board approved a proposal for raising funds through various equity-linked securities.

- Commissioned major capacity expansion at Texas manufacturing facility, increasing total manufacturing capacity to approximately 268,000 MTPA. - Guides CrudeChem (Oil & Gas) revenue of USD 100 million in FY27 and USD 200 million in FY28. - Expects full utilization of CrudeChem capacity in coming quarters, leveraging current 63% utilization and potential for 30-40% additional business. - Aims for better EBITDA margins, having achieved 15.70% in Q1 FY27 driven by synergies, cost reduction, and green chemistry products. - Textile Specialty Chemicals business is well-positioned for sustainable long-term growth and expects improvement in upcoming quarters. - Secured a significant order through a customer with Aramco (USD 8 billion using Fineotex's specialty package). - Focused on expanding global footprint, strengthening customer relations, and investing in innovation for diversified specialty chemicals business.

- Audio recording of the Investors and Analyst Concall held on July 24, 2026, is now available on the company's website. - The concall discussed the financial performance for Q1 FY 2026-2027.

- Consolidated Revenue ₹386.72 Cr vs ₹146.22 Cr (▲164.48% YoY) - EBITDA ₹59.14 Cr vs ₹25.20 Cr (▲134.69% YoY) - PAT ₹48.21 Cr vs ₹25.03 Cr (▲92.67% YoY) - EBITDA Margin 15.70% vs 17.23% (▼153bps)

- Consolidated Total Income ₹386.72 Cr vs ₹146.22 Cr (▲164.48% YoY) - Operational EBITDA ₹59.14 Cr vs ₹25.20 Cr (▲134.74% YoY) - PAT ₹48.21 Cr vs ₹25.03 Cr (▲92.61% YoY) - EBITDA Margin 15.29% vs 17.23% (▼194bps) - Volume growth of ~130.84% YoY. - Consolidated Return on Invested Capital (ROIC) for Q1-FY27 is ~33.06%.

- Concall Schedule - Concall Date: Friday, July 24, 2026 - Concall Time: 5:00 P.M. (IST) - Purpose: To discuss Q1 FY27 operational and financial performance.

- Trading window for Fineotex Chemical Limited closed from July 01, 2026, until 48 hours after the declaration of financial results for the quarter ended June 30, 2026. This is to prevent insider trading.

- Concall Schedule - Concall Date: June 24, 2026 - Concall Time: 03:30 P.M. (IST)

- Concall Schedule - Concall Date: June 20, 2026 - Concall Time: 11:30 AM – 12:30 PM (IST)

- Investor/Analyst Meet Schedule - Meet Date: June 17, 2026 (Wednesday) - Meet Time: 09:00 AM – 03:00 PM (IST)

New Filing detected. See link for details.

New Filing detected. See link for details.

New Filing detected. See link for details.

Fineotex Chemical Limited announced the availability of the audio recording for its Investors and Analyst Call held on May 18, 2026. The call discussed the company's financial performance for Q4 FY 2025-2026, and the recording is accessible on the company's website.

Consolidated Revenue ₹313.73Cr vs ₹119.79Cr (▲162% YoY), EBITDA ₹43.69Cr vs ₹21.29Cr (▲105% YoY), PAT ₹43.79Cr vs ₹20.13Cr (▲118% YoY). EBITDA Margin 13.93% vs 17.77% (▼384bps). The company reported strong operational and financial performance, driven by the successful integration of its oilfield specialty chemicals business and expansion into a new 15-acre facility in Midland, enhancing capacity and capabilities.

Consolidated Revenue ₹313.73Cr vs ₹119.79Cr (▲161.91% YoY), Operational EBITDA ₹53.15Cr vs ₹28.83Cr (▲85.87% YoY), PAT ₹43.80Cr vs ₹20.13Cr (▲117.56% YoY). EBITDA Margin 16.94% vs 24.06% (▼712bps). A final dividend of Rs. 0.05/- per equity share was recommended.

Consolidated Revenue ₹313.73 Cr vs ₹119.79 Cr (▲161.91% YoY), EBITDA ₹53.15 Cr vs ₹28.83 Cr (▲85.87% YoY), PAT ₹43.80 Cr vs ₹20.13 Cr (▲117.56% YoY). EBITDA Margin 16.9% vs 24.1% (▼720bps).

Fineotex Chemical Limited announced an Earnings Conference Call with analysts and investors on Monday, May 18, 2026, at 10:00 AM (IST) to discuss the operational and financial performance for Q4 and Full Year FY2025-26.